RT Journal Article
SR Electronic
T1 The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.29.21259494
DO 10.1101/2021.06.29.21259494
A1 Dirkx, Kirsten
A1 Mulder, Bert
A1 Post, Annelies
A1 Rutten, Martijn
A1 Swanink, Caroline
A1 Wertheim, Heiman
A1 Cremers, Amelieke
YR 2021
UL http://medrxiv.org/content/early/2021/07/03/2021.06.29.21259494.abstract
AB Streptococcus pneumoniae is the main bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less pneumococcal disease was identified by surveillance systems around the world. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates. Here, we explore additional factors that have contributed to the instant drop in pneumococcal disease cases captured in surveillance. Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance. Depending on setting, we discuss alternative monitoring strategies that could improve sight on pneumococcal disease dynamics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was initiated by the BACON study group (Bacteremia Collection East Netherlands) as part of a research project on Genomic epistasis of invasive S. pneumoniae funded by a Research Grant 2020 from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to A.J.H. Cremers.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study is approved by a central Medical Ethics Committee as well as the local Ethics Committees of all participating hospitals, Radboudumc, Rijnstate Hospital and Canisius-Wilhelmina Hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request and in accordance with approved study procedures.